SCHEDULE 13G: Sio Capital Management Discloses 5.06% Passive Stake in Vaxart, Inc.

Sio Capital Management, LLC has reported a 5.06% beneficial ownership stake in Vaxart, Inc., holding 11,515,315 shares as of December 31, 2024, in a Schedule 13G filing.

Summary

• Sio Capital Management, LLC filed a Schedule 13G with the SEC, disclosing beneficial ownership of 11,515,315 shares of Vaxart, Inc. common stock.
• This ownership represents 5.06% of Vaxart, Inc.'s total outstanding common stock.
• The reported ownership stake is as of December 31, 2024.
• Sio Capital Management, LLC, a Delaware limited liability company, operates as a registered investment adviser to affiliated funds that directly hold these shares.
• The filing indicates that Sio Capital Management, LLC possesses shared voting power and shared dispositive power over all 11,515,315 shares.
• The Schedule 13G certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of Vaxart, Inc.
• The 5.06% ownership percentage is calculated based on 227,479,881 shares of Vaxart, Inc. common stock outstanding as of November 6, 2024, as reported in Vaxart's Form 10-Q filed on November 13, 2024.

Sentiment

Score: 6

Explanation: The filing is largely neutral as a regulatory disclosure. However, the disclosure of a new 5.06% institutional stake by Sio Capital Management can be viewed as a moderately positive signal of institutional interest in Vaxart, Inc., suggesting potential confidence in the company's long-term prospects.

Positives

• The disclosure of a new 5.06% stake by Sio Capital Management, an institutional investor, indicates significant institutional interest in Vaxart, Inc.
• Filing a Schedule 13G suggests a passive investment intent, implying a long-term holding strategy rather than an activist one.

Risks

• The filing includes a standard legal disclaimer stating that neither Sio GP, LLC nor Michael Castor (who controls both Sio and Sio GP) should be deemed beneficial owners of the shares for purposes of Section 13(d) of the Exchange Act, despite their oversight and control over the investment decisions.

Future Outlook

NA

Industry Context

This Schedule 13G filing indicates that Sio Capital Management, LLC, an investment adviser, has taken a significant passive stake in Vaxart, Inc. Such filings are common for institutional investors who acquire more than 5% of a company's shares but do not intend to influence or change control of the company. It signals institutional confidence or strategic positioning within the biotechnology sector, where Vaxart operates, without implying any direct operational or strategic involvement.

Stakeholder Impact

• **Shareholders**: Provides transparency regarding significant institutional ownership, potentially signaling confidence from a professional investment firm. Existing shareholders may view this as a positive indicator of institutional interest.
• **Company Management**: Awareness of a new significant shareholder, though the filing indicates a passive stake not intended to influence control.

Key Dates

Keywords

Vaxart Inc., Sio Capital Management, Schedule 13G, Beneficial Ownership, Common Stock, Investment Adviser, Institutional Investor, SEC Filing